Toggle Main Menu Toggle Search

Open Access padlockePrints

Multigenerational epigenetic adaptation of the hepatic wound-healing response

Lookup NU author(s): Dr Mujdat Zeybel, Dr Timothy Hardy, Frances Wong, Professor John Mathers, Christopher Fox, Dr Agata Page, Professor Fiona OakleyORCiD, Professor Alastair BurtORCiD, Dr Caroline WilsonORCiD, Professor Quentin AnsteeORCiD, Dr Matthew Barter, Dr Steven MassonORCiD, Dr Ahmed Elsharkawy, Professor Derek Mann, Professor Jelena Mann

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

We investigated whether ancestral liver damage leads to heritable reprogramming of hepatic wound healing in male rats. We found that a history of liver damage corresponds with transmission of an epigenetic suppressive adaptation of the fibrogenic component of wound healing to the male F-1 and F-2 generations. Underlying this adaptation was less generation of liver myofibroblasts, higher hepatic expression of the antifibrogenic factor peroxisome proliferator-activated receptor gamma (PPAR-gamma) and lower expression of the profibrogenic factor transforming growth factor beta 1 (TGF-beta 1) compared to rats without this adaptation. Remodeling of DNA methylation and histone acetylation underpinned these alterations in gene expression. Sperm from rats with liver fibrosis were enriched for the histone variant H2A.Z and trimethylation of histone H3 at Lys27 (H3K27me3) at PPAR-gamma chromatin. These modifications to the sperm chromatin were transmittable by adaptive serum transfer from fibrotic rats to naive rats and similar modifications were induced in mesenchymal stem cells exposed to conditioned media from cultured rat or human myofibroblasts. Thus, it is probable that a myofibroblast-secreted soluble factor stimulates heritable epigenetic signatures in sperm so that the resulting offspring better adapt to future fibrogenic hepatic insults. Adding possible relevance to humans, we found that people with mild liver fibrosis have hypomethylation of the PPARG promoter compared to others with severe fibrosis.


Publication metadata

Author(s): Zeybel M, Hardy T, Wong YK, Mathers JC, Fox CR, Gackowska A, Oakley F, Burt AD, Wilson CL, Anstee QM, Barter MJ, Masson S, Elsharkawy AM, Mann DA, Mann J

Publication type: Article

Publication status: Published

Journal: Nature Medicine

Year: 2012

Volume: 18

Issue: 9

Pages: 1369-U110

Print publication date: 02/09/2012

ISSN (print): 1078-8956

ISSN (electronic): 1546-170X

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/nm.2893

DOI: 10.1038/nm.2893


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Biotechnology and Biological Sciences Research Council
Engineering and Physical Sciences Research Council
National Institute for Health Research
Newcastle Biomedical Research Centre
Turkish Association For The Study Of The Liver
Economic and Social Research Council
Lifelong Health and Wellbeing cross council initiative by the Medical Research Council
1U01AA018663-01US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism
R21AA016682US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism
WT074472MAWellcome Trust
WT086755MAWellcome Trust

Share